BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15682426)

  • 1. X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis.
    Kanegane H; Ito Y; Ohshima K; Shichijo T; Tomimasu K; Nomura K; Futatani T; Sumazaki R; Miyawaki T
    Am J Hematol; 2005 Feb; 78(2):130-3. PubMed ID: 15682426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-linked lymphoproliferative disease in an adult.
    Hoshino T; Kanegane H; Doki N; Irisawa H; Sakura T; Nojima Y; Miyawaki S; Miyawaki T
    Int J Hematol; 2005 Jul; 82(1):55-8. PubMed ID: 16105760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-associated lymphoproliferative syndromes: studies in two European families.
    Schuster V; Dohrmann E; Kreth HW
    Cancer Detect Prev; 1991; 15(1):65-7. PubMed ID: 1646073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus (EBV) and X-linked lymphoproliferative syndrome (XLP).
    Tatsumi E; Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S109-13. PubMed ID: 3030340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cutaneous and neurologic vasculitis disclosing EBV-selective immunodeficiency].
    Grosieux C; Amoric JC; Mechinaud F; Moreau A; Mussini JM; Fesneau H; Dreno B; Bureau B; Stalder JF; Litoux P
    Ann Dermatol Venereol; 1996; 123(6-7):387-92. PubMed ID: 8959062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease.
    Grierson HL; Skare J; Hawk J; Pauza M; Purtilo DT
    Am J Med Genet; 1991 Sep; 40(3):294-7. PubMed ID: 1683154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-linked lymphoproliferative syndrome.
    Sullivan JL; Woda BA
    Immunodefic Rev; 1989; 1(4):325-47. PubMed ID: 2561059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocytic vasculitis in X-linked lymphoproliferative disease.
    Dutz JP; Benoit L; Wang X; Demetrick DJ; Junker A; de Sa D; Tan R
    Blood; 2001 Jan; 97(1):95-100. PubMed ID: 11133747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of families wherein a single male manifests a phenotype of X-linked lymphoproliferative disease (XLP).
    Grierson HL; Skare J; Church J; Silberman T; Davis JR; Kobrinsky N; McGregor R; Israels S; McCarty J; Andrews LG
    Am J Med Genet; 1993 Sep; 47(4):458-63. PubMed ID: 8256804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of telomere erosion on memory CD8+ T cells in patients with X-linked lymphoproliferative syndrome.
    Plunkett FJ; Franzese O; Belaramani LL; Fletcher JM; Gilmour KC; Sharifi R; Khan N; Hislop AD; Cara A; Salmon M; Gaspar HB; Rustin MH; Webster D; Akbar AN
    Mech Ageing Dev; 2005 Aug; 126(8):855-65. PubMed ID: 15992610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necrotizing lymphoid vasculitis in X-linked lymphoproliferative syndrome.
    Loeffel S; Chang CH; Heyn R; Harada S; Lipscomb H; Sinangil F; Volsky DJ; McClain K; Ochs H; Purtilo DT
    Arch Pathol Lab Med; 1985 Jun; 109(6):546-50. PubMed ID: 2986573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
    Masucci MG; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo DT
    Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-linked lymphoproliferative syndrome. An immunodeficiency disorder with acquired agammaglobulinemia, fatal infectious mononucleosis, or malignant lymphoma.
    Purtilo DT
    Arch Pathol Lab Med; 1981 Mar; 105(3):119-21. PubMed ID: 6894075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
    Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant B-cell lymphoma following and associated with infectious mononucleosis. A comparison of two cases.
    Pattengale PK; Taylor CR; Pegalow C
    Am J Pediatr Hematol Oncol; 1981; 3(1):35-42. PubMed ID: 6263125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two brothers in a Malaysian family with X-linked lymphoproliferative disease--a case report.
    Hany A; Thong MK; Lin HP
    Singapore Med J; 1996 Jun; 37(3):325-7. PubMed ID: 8942243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection.
    Shinozaki K; Kanegane H; Matsukura H; Sumazaki R; Tsuchida M; Makita M; Kimoto Y; Kanai R; Tsumura K; Kondoh T; Moriuchi H; Miyawaki T
    Int Immunol; 2002 Oct; 14(10):1215-23. PubMed ID: 12356686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP).
    Brandau O; Schuster V; Weiss M; Hellebrand H; Fink FM; Kreczy A; Friedrich W; Strahm B; Niemeyer C; Belohradsky BH; Meindl A
    Hum Mol Genet; 1999 Dec; 8(13):2407-13. PubMed ID: 10556288
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.